TESTOSTERONE DOSE RESPONSE IN SURGICALLY MENOPAUSAL WOMEN

接受手术的绝经期女性的睾酮剂量反应

基本信息

  • 批准号:
    7379521
  • 负责人:
  • 金额:
    $ 2.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-12-01 至 2006-11-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Normally women produce testosterone in their ovaries even after menopause. Women who have had both ovaries removed by surgery usually have low testosterone levels which may contribute to reduced sexual function, muscle function and general sense of well being. The purpose of this study is to determine what the most appropriate dose of testosterone is to give to women who have had their ovaries removed before menopause and have low testosterone levels in their blood. The most appropriate dose of testosterone will be the amount of testosterone that maximizes the beneficial effects while minimizing side effects. We will do this by randomly assigning 140 women between the ages of 21 and 60 who have had their ovaries removed to four groups which receive either placebo or one of three doses of testosterone by weekly injections for 6 months (double blind.) Subjects will also be treated with an estrogen patch during the study. The effects of testosterone will be determined by measuring lean body tissue, muscle size, muscle strength and leg power, sexual function and brain function. We will also measure plasma lippids (cholesterol in the blood and some functions of insulin sensitivity (how the body handles sugar).
该子项目是利用 NIH/NCRR 资助的中心拨款提供的资源的众多研究子项目之一。子项目和研究者 (PI) 可能已从另一个 NIH 来源获得主要资金,因此可以在其他 CRISP 条目中得到体现。列出的机构是中心的机构,不一定是研究者的机构。通常,女性即使在绝经后也会在卵巢中产生睾酮。通过手术切除双侧卵巢的女性通常睾酮水平较低,这可能会导致性功能、肌肉功能和总体幸福感下降。本研究的目的是确定对于绝经前切除卵巢且血液中睾酮水平较低的女性,最合适的睾酮剂量是多少。最合适的睾酮剂量是能够最大化有益效果同时最小化副作用的睾酮量。为此,我们将 140 名年龄在 21 岁至 60 岁之间、已切除卵巢的女性随机分配到四组,每组接受安慰剂或每周注射三剂睾酮中的一种,持续 6 个月(双盲)。研究期间,受试者还将接受雌激素贴片治疗。睾酮的作用将通过测量瘦身体组织、肌肉大小、肌肉力量和腿部力量、性功能和大脑功能来确定。我们还将测量血浆脂质(血液中的胆固醇和胰岛素敏感性的一些功能(身体如何处理糖)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHALENDER BHASIN其他文献

SHALENDER BHASIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHALENDER BHASIN', 18)}}的其他基金

NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
NAD 增强治疗糖尿病肾病:一项随机对照试验
  • 批准号:
    10430705
  • 财政年份:
    2022
  • 资助金额:
    $ 2.82万
  • 项目类别:
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
NAD 增强治疗糖尿病肾病:一项随机对照试验
  • 批准号:
    10668324
  • 财政年份:
    2022
  • 资助金额:
    $ 2.82万
  • 项目类别:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
Sirtuin-NAD 激活剂治疗阿尔茨海默病的概念验证试验
  • 批准号:
    10311161
  • 财政年份:
    2021
  • 资助金额:
    $ 2.82万
  • 项目类别:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
Sirtuin-NAD 激活剂治疗阿尔茨海默病的概念验证试验
  • 批准号:
    10457489
  • 财政年份:
    2021
  • 资助金额:
    $ 2.82万
  • 项目类别:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
Sirtuin-NAD 激活剂治疗阿尔茨海默病的概念验证试验
  • 批准号:
    10634622
  • 财政年份:
    2021
  • 资助金额:
    $ 2.82万
  • 项目类别:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
改善雄激素缺乏的前列腺癌幸存者的生活质量
  • 批准号:
    10398005
  • 财政年份:
    2018
  • 资助金额:
    $ 2.82万
  • 项目类别:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
  • 批准号:
    9767249
  • 财政年份:
    2018
  • 资助金额:
    $ 2.82万
  • 项目类别:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
  • 批准号:
    10159744
  • 财政年份:
    2018
  • 资助金额:
    $ 2.82万
  • 项目类别:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
  • 批准号:
    10398790
  • 财政年份:
    2018
  • 资助金额:
    $ 2.82万
  • 项目类别:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
改善雄激素缺乏的前列腺癌幸存者的生活质量
  • 批准号:
    9918241
  • 财政年份:
    2018
  • 资助金额:
    $ 2.82万
  • 项目类别:

相似海外基金

Testosterone Dose-Response on Cardiometabolic Outcomes in Surgically Menopausal W
睾酮剂量反应对手术绝经 W 患者心脏代谢结果的影响
  • 批准号:
    8596189
  • 财政年份:
    2013
  • 资助金额:
    $ 2.82万
  • 项目类别:
CLINICAL TRIAL: TESTOSTERONE DOSE RESPONSE IN SURGICALLY POSTMENOPAUSAL WOMEN
临床试验:绝经后女性手术后的睾酮剂量反应
  • 批准号:
    8359857
  • 财政年份:
    2011
  • 资助金额:
    $ 2.82万
  • 项目类别:
CLINICAL TRIAL: TESTOSTERONE DOSE RESPONSE IN SURGICALLY POSTMENOPAUSAL WOMEN
临床试验:绝经后女性手术后的睾酮剂量反应
  • 批准号:
    8173594
  • 财政年份:
    2010
  • 资助金额:
    $ 2.82万
  • 项目类别:
TESTOSTERONE DOSE RESPONSE IN SURGICALLY POSTMENOPAUSAL WOMEN
绝经后女性手术后的睾酮剂量反应
  • 批准号:
    7960759
  • 财政年份:
    2009
  • 资助金额:
    $ 2.82万
  • 项目类别:
TESTOSTERONE DOSE RESPONSE IN SURGICALLY POSTMENOPAUSAL WOMEN
绝经后女性手术后的睾酮剂量反应
  • 批准号:
    7720968
  • 财政年份:
    2008
  • 资助金额:
    $ 2.82万
  • 项目类别:
TESTOSTERONE DOSE RESPONSE IN SURGICALLY MENOPAUSAL WOMEN
接受手术的绝经期女性的睾酮剂量反应
  • 批准号:
    7606264
  • 财政年份:
    2007
  • 资助金额:
    $ 2.82万
  • 项目类别:
Sarcopenia: Testosterone Dose Response in Older Men
肌肉减少症:老年男性的睾酮剂量反应
  • 批准号:
    7042089
  • 财政年份:
    2003
  • 资助金额:
    $ 2.82万
  • 项目类别:
SARCOPENIA: TESTOSTERONE DOSE RESPONSE IN OLDER MEN
肌肉减少症:老年男性的睾酮剂量反应
  • 批准号:
    6416309
  • 财政年份:
    2000
  • 资助金额:
    $ 2.82万
  • 项目类别:
SARCOPENIA: TESTOSTERONE DOSE RESPONSE IN OLDER MEN
肌肉减少症:老年男性的睾酮剂量反应
  • 批准号:
    6306596
  • 财政年份:
    1999
  • 资助金额:
    $ 2.82万
  • 项目类别:
SARCOPENIA: TESTOSTERONE DOSE RESPONSE IN OLDER MEN
肌肉减少症:老年男性的睾酮剂量反应
  • 批准号:
    6264891
  • 财政年份:
    1998
  • 资助金额:
    $ 2.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了